Saturday, 31 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleVentureBeat AI

Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews

View original at venturebeat.com
VentureBeat AI - Enterprise Ai Title: Listen Labs raises $69M after viral billboard hiring stunt to scale AI customer interviews Date: 2026-01-16 14:01 Source: https://venturebeat.com/technology/listen-labs-raises-usd69m-after-viral-billboard-hiring-stunt-to-scale-ai <p>Alfred Wahlforss was running out of options…
Opening lines of the source · VentureBeat AI · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • When you obsess over customers, everything else follows. Teams that use Listen bring the customer into every decision, from marketing to product, and when the customer is delighted, everyone is.

    80% confidence
  • 95% of AI pilots fail to move into production, which is why Listen Labs emphasizes quality over demos.

    80% confidence
  • Surveys give false precision because people answer the same question without nuance; you can't get outliers and people are not honest on surveys.

    80% confidence
  • Scheduling traditional focus groups with children is difficult due to school, sports, dinner, and homework; Listen Labs overcame this by fitting into children's schedules.

    80% confidence
  • Rampant fraud is endemic in the market research industry, with large companies sending fraudulent enterprise buyer profiles.

    80% confidence
  • The market research industry is approximately $140 billion annually, populated by legacy players vulnerable to disruption.

    80% confidence
  • Simple Modern went from 'Should we even have this product?' to 'How should we launch it?' after receiving rapid Listen Labs feedback.

    80% confidence
  • Listen Labs is building synthetic customer simulation to extrapolate from interview data and create simulated user voices for automated product decisions.

    80% confidence
  • Listen Labs' engineering team has 30% IOI medalists, does not train on customer data, and automatically scrubs sensitive PII.

    80% confidence
  • Listen Labs' quality guard results in participants talking three times more and being much more honest on sensitive topics like politics and mental health.

    80% confidence
  • AI-powered automated product development loops will enable companies to almost autonomously ship products by combining automated coding and automated user research.

    80% confidence
  • Emeritus did not have to replace any responses because of fraud or gibberish information when using Listen Labs.

    80% confidence
  • As something gets cheaper, you don't need less of it—you want more of it; there is infinite demand for customer understanding.

    80% confidence
  • Listen Labs removed the drudgery of research and brought the fun and joy back into research work at Microsoft.

    80% confidence
  • Traditional customer research at Microsoft could take four to six weeks, causing missed opportunities to influence decisions.

    80% confidence
  • Sling Money considers Listen Labs a total game changer, creating surveys in ten minutes and receiving same-day results.

    80% confidence
  • Listen Labs' Berghain billboard generated approximately 5 million social media views.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com